Skip Navigation



NDT Advance Access published online on May 6, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp211
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/8/2595    most recent
gfp211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bacchetta, J.
Right arrow Articles by Cochat, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacchetta, J.
Right arrow Articles by Cochat, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism

Justine Bacchetta1,2, Ingrid Plotton2,3, Bruno Ranchin1, Thierry Vial4, Marc Nicolino2,5, Yves Morel2,3 and Pierre Cochat1,2

1 Service de Néphrologie et Rhumatologie Pédiatriques, Centre de Référence des Maladies Rénales Rares, Hôpital Femme Mère Enfant, Bron 2 Université de Lyon, F-69008, Lyon 3 Service d’Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon, Bron 4 Centre de Pharmacovigilance des Hospices Civils de Lyon, Lyon 5 Service d’Endocrinologie Pédiatrique, Hôpital Femme Mère Enfant, Lyon, France

Correspondence and offprint requests to: Justine Bacchetta; E-mail: justine.bacchetta{at}chu-lyon.fr



  Abstract

Puberty is often delayed in children with chronic kidney disease. A 5-year-old boy suffering from severe chronic kidney disease due to a mutation in the TCF2 gene presented with a clinical precocious peripheral puberty 3 weeks after introducing cinacalcet and 2 months after introducing lanthanum carbonate. A retrospective measurement of serum sexual and adrenal hormones before the introduction of cinacalcet but after the introduction of lanthanum carbonate revealed an asymptomatic biological underlying precocious puberty. With more than 1-year follow-up, the aetiology of this precocious puberty remains unexplained. Cinacalcet can be responsible for hypotestosteronaemia in adults, but no case of precocious puberty has been described in association with cinacalcet so far. Natural lanthanides can activate in vitro the calcium sensor receptor, but there are no clinical data about side effects of lanthanum carbonate on sexual hormones. An unknown phenotype of TCF2 mutation may also be discussed. Monitoring of plasma testosterone in patients receiving unlicensed paediatric drugs for managing hyperparathyroidism and presenting with a change in genitals is therefore recommended.

Keywords: cinacalcet; chronic kidney disease; lanthanum; precocious puberty; TCF2 mutation

Received for publication: 2. 4.08
Accepted in revised form: 16. 4.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.